Endo Provides Select First-Quarter 2024 Financial Results for Endo International plc

Endo, Inc. ("Endo" or the "Company"), a newly formed entity that recently acquired (the "Acquisition") substantially all of the assets of Endo International plc ("EIP") as contemplated by EIP's plan of reorganization (the "Plan"), today made select...

Related Keywords

Canada , ,Branded Pharmaceuticals ,International Pharmaceuticals ,Linkedin ,Pfizer Inc ,Takeda Pharmaceutical United Statesa Inc ,Company Investor Relations Department ,Copies Of The Company ,Nendo Inc ,Takeda Pharmaceuticals United States Inc ,Prnewswire Endo Inc ,Financial Results For Endo International ,Endo International ,Exchange Commission ,Generic Pharmaceuticals ,Paladin Labs Inc ,Provides Select First Quarter ,Months Ended March ,Net Income ,Adjusted Net Income ,Net Loss ,Note Regarding Forward Looking Statements ,Gross Margin ,Total Revenues ,Takeda Pharmaceutical United Statesa ,Sterile Injectables ,Takeda Pharmaceuticals United States ,Paladin Labs ,Condensed Consolidated Statement ,Condensed Consolidated Balance Sheet ,Cash Flow ,Qualified Settlement ,Supplemental Financial Information ,Condensed Consolidated Statements ,Accounting Standards Codification Topic ,Securities Act ,Investor Relations Department ,